EGRX logo

Eagle Pharmaceuticals (EGRX) Earnings Per Share

Annual EPS

$2.73
+$3.39+513.64%

December 31, 2022

Summary

Performance

1-Year Change

+513.64%

3-Year Change

+170.3%

5-Year Change

-16.51%

15-Year Change

-16.51%

EGRX EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.49%
EGRX annual earnings per share is higher than 93.49% of companies in Healthcare sector

High & Low

All-time High

$4.96
EGRX annual earnings per share is currently -44.96% below its historical high of $4.96

3-Year Low

-$0.66

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
EGRX previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
EGRX next annual earnings announcement has not yet been scheduled

OtherEGRXprofitabilitymetrics:

Annual Revenue

$316.61 M
EGRX annual revenue is $316.61 million

Annual Gross Profit

$221.67 M
EGRX annual gross profit is $221.67 million

Annual Operating Profit

$80.96 M
EGRX annual operating income is $80.96 million

Annual Net Income

$35.64 M
EGRX annual net profit is $35.64 million

Quarterly EPS

$0.39
-$0.05-11.36%

June 30, 2023

Summary

Performance

3-Month Change

-11.36%

1-Year Change

+152.7%

3-Year Change

+2050%

5-Year Change

+129.41%

EGRX Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.33%
EGRX quarterly earnings per share is higher than 89.33% of companies in Healthcare sector

High & Low

All-time High

$3.52
EGRX quarterly earnings per share is currently -88.92% below its historical high of $3.52

3-Year Low

-$0.74

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
EGRX previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
EGRX next earnings announcement has not yet been scheduled

OtherEGRXprofitabilitymetrics:

Quarterly Revenue

$64.65 M
EGRX quarterly revenue is $64.65 million

Quarterly Gross Profit

$47.79 M
EGRX quarterly gross profit is $47.79 million

Quarterly Operating Profit

$10.30 M
EGRX quarterly operating income is $10.30 million

Quarterly Net Income

$5.16 M
EGRX quarterly net profit is $5.16 million

TTM EPS

$0.91
+$1.13+513.64%

June 30, 2023

Summary

Performance

3-Month Change

+513.64%

1-Year Change

-48.3%

3-Year Change

+375.76%

5-Year Change

-9%

EGRX TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.98%
EGRX TTM earnings per share is higher than 88.98% of companies in Healthcare sector

High & Low

All-time High

$6.47
EGRX TTM earnings per share is currently -85.94% below its historical high of $6.47

3-Year Low

-$0.67

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
EGRX previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
EGRX next earnings announcement has not yet been scheduled

OtherEGRXprofitabilitymetrics:

Annual Revenue

$316.61 M
EGRX annual revenue is $316.61 million

Annual Gross Profit

$221.67 M
EGRX annual gross profit is $221.67 million

Annual Operating Profit

$80.96 M
EGRX annual operating income is $80.96 million

Annual Net Income

$35.64 M
EGRX annual net profit is $35.64 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

$2.73
EGRX annual earnings per share is $2.73

Annual Net Income

$35.64 M
EGRX annual net profit is $35.64 million

Shares Outstanding

12.99 M
EGRX shares outstanding is 12.99 million

EGRX EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+513.6%+152.7%-48.3%
3 y3 years+170.3%+2050.0%+375.8%
5 y5 years-16.5%+129.4%-9.0%

EGRX EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+513.6%-88.6%+152.7%-67.2%+235.8%
5 y5-yearat high+513.6%-88.6%+152.7%-67.2%+235.8%
alltimeall time-45.0%+223.8%-88.9%+152.7%-85.9%+156.5%

Eagle Pharmaceuticals EPS History

DateAnnualQuarterlyTTM
Jun 2023
-
$0.39(-11.4%)
$0.91(-513.6%)
Mar 2023
-
$0.44(-29.0%)
-$0.22(-108.0%)
Dec 2022
$2.73(-513.6%)
$0.62(-214.8%)
$2.75(+66.7%)
Sep 2022
-
-$0.54(-27.0%)
$1.65(-6.3%)
Jun 2022
-
-$0.74(-121.7%)
$1.76(-36.5%)
Mar 2022
-
$3.41(-810.4%)
$2.77(-513.4%)
Dec 2021
-$0.66(-175.9%)
-$0.48(+11.6%)
-$0.67(-267.5%)
Sep 2021
-
-$0.43(-259.3%)
$0.40(-70.1%)
Jun 2021
-
$0.27(-1000.0%)
$1.34(+27.6%)
Mar 2021
-
-$0.03(-105.1%)
$1.05(+20.7%)
Dec 2020
$0.87(-13.9%)
$0.59(+15.7%)
$0.87(+148.6%)
Sep 2020
-
$0.51(-2650.0%)
$0.35(-206.1%)
Jun 2020
-
-$0.02(-90.5%)
-$0.33(-294.1%)
Mar 2020
-
-$0.21(-400.0%)
$0.17(-83.0%)
Dec 2019
$1.01(-51.7%)
$0.07(-141.2%)
$1.00(-44.1%)
Sep 2019
-
-$0.17(-135.4%)
$1.79(-37.6%)
Jun 2019
-
$0.48(-22.6%)
$2.87(+12.1%)
Mar 2019
-
$0.62(-27.9%)
$2.56(+21.3%)
Dec 2018
$2.09(-36.1%)
$0.86(-5.5%)
$2.11(+15.3%)
Sep 2018
-
$0.91(+435.3%)
$1.83(-3.7%)
Jun 2018
-
$0.17(0.0%)
$1.90(-5.5%)
Mar 2018
-
$0.17(-70.7%)
$2.01(-38.3%)
DateAnnualQuarterlyTTM
Dec 2017
$3.27(-34.1%)
$0.58(-40.8%)
$3.26(-47.4%)
Sep 2017
-
$0.98(+250.0%)
$6.20(+4.2%)
Jun 2017
-
$0.28(-80.3%)
$5.95(-8.0%)
Mar 2017
-
$1.42(-59.7%)
$6.47(+29.7%)
Dec 2016
$4.96(+3000.0%)
$3.52(+382.2%)
$4.99(+224.0%)
Sep 2016
-
$0.73(-8.8%)
$1.54(+862.5%)
Jun 2016
-
$0.80(-1433.3%)
$0.16(-113.7%)
Mar 2016
-
-$0.06(-185.7%)
-$1.17(-685.0%)
Dec 2015
$0.16(-108.1%)
$0.07(-110.8%)
$0.20(-176.9%)
Sep 2015
-
-$0.65(+22.6%)
-$0.26(0.0%)
Jun 2015
-
-$0.53(-140.5%)
-$0.26(-533.3%)
Mar 2015
-
$1.31(-435.9%)
$0.06(-103.7%)
Dec 2014
-
-$0.39(-40.0%)
-$1.61(+4.9%)
Sep 2014
-$1.97(+110.6%)
-$0.65(+209.5%)
-$1.54(+62.2%)
Jun 2014
-
-$0.21(-41.7%)
-$0.95(+23.4%)
Mar 2014
-
-$0.36(+14.2%)
-$0.77(-18.3%)
Dec 2013
-
-$0.32(+413.4%)
-$0.94(+0.3%)
Sep 2013
-$0.94(-57.6%)
-$0.06(+102.6%)
-$0.94(+7.0%)
Jun 2013
-
-$0.03(-94.3%)
-$0.87(+3.6%)
Mar 2013
-
-$0.53(+70.1%)
-$0.84(+170.1%)
Dec 2012
-
-$0.31
-$0.31
Sep 2012
-$2.21
-
-

FAQ

  • What is Eagle Pharmaceuticals annual earnings per share?
  • What is the all time high annual EPS for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals annual EPS year-on-year change?
  • What is Eagle Pharmaceuticals quarterly earnings per share?
  • What is the all time high quarterly EPS for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals quarterly EPS year-on-year change?
  • What is Eagle Pharmaceuticals TTM earnings per share?
  • What is the all time high TTM EPS for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals TTM EPS year-on-year change?

What is Eagle Pharmaceuticals annual earnings per share?

The current annual EPS of EGRX is $2.73

What is the all time high annual EPS for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high annual earnings per share is $4.96

What is Eagle Pharmaceuticals annual EPS year-on-year change?

Over the past year, EGRX annual earnings per share has changed by +$3.39 (+513.64%)

What is Eagle Pharmaceuticals quarterly earnings per share?

The current quarterly EPS of EGRX is $0.39

What is the all time high quarterly EPS for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high quarterly earnings per share is $3.52

What is Eagle Pharmaceuticals quarterly EPS year-on-year change?

Over the past year, EGRX quarterly earnings per share has changed by +$1.13 (+152.70%)

What is Eagle Pharmaceuticals TTM earnings per share?

The current TTM EPS of EGRX is $0.91

What is the all time high TTM EPS for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high TTM earnings per share is $6.47

What is Eagle Pharmaceuticals TTM EPS year-on-year change?

Over the past year, EGRX TTM earnings per share has changed by -$0.85 (-48.30%)